Literature DB >> 11843820

Enhanced T-lineage acute lymphoblastic leukaemia cell survival on bone marrow stroma requires involvement of LFA-1 and ICAM-1.

S S Winter1, J J Sweatman, M B Lawrence, T H Rhoades, A L Hart, R S Larson.   

Abstract

The bone marrow (BM) microenvironment supports leukaemia cell survival and proliferation. The roles played by adhesive receptor interactions in the survival of T-lineage acute lymphoblastic leukaemia (T-ALL) cells on BM stromal cells are not well understood. Recently, we have developed an assay that partially recapitulates the BM microenvironment using HS-5 BM stromal cells. In this assay, the magnitude of ex vivo T-ALL lymphoblast survival predicts patient outcome. We examined the molecular basis for cell-cell adhesive events leading to T-ALL lymphoblast survival on HS-5 and on donor-derived BM stroma. Lympho cyte function-associated antigen-1 (LFA-1) on T-ALL cell lines bound intercellular adhesion molecule-1 (ICAM-1) on HS-5 monolayers, and survival was inhibited 85-98% with monoclonal antibodies directed against LFA-1 or ICAM-1. We compared these results with patient-derived T-ALL lymphoblasts co-cultured on either HS-5 BM or normal BM monolayers and found that LFA-1 and ICAM-1 were required, but not alone sufficient for ex vivo leukaemic cell survival. On normal BM stroma, but not HS-5 monolayers, two additional adhesion molecules, vascular cell adhesion molecule-1 (VCAM-1) and E-selectin, were highly expressed and contributed to T-ALL cell survival. This is the first report to demonstrate the importance of LFA-1/ICAM-1-mediated adhesion as a critical event in a cascade of cell surface receptor-ligand interactions that regulate T-ALL survival in the BM microenvironment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11843820     DOI: 10.1046/j.1365-2141.2001.03182.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  28 in total

Review 1.  LFA-1 on leukemic cells as a target for therapy or drug delivery.

Authors:  Rungsinee Phongpradist; Chuda Chittasupho; Siriporn Okonogi; Teruna Siahaan; Songyot Anuchapreeda; Chadarat Ampasavate; Cory Berkland
Journal:  Curr Pharm Des       Date:  2010-07       Impact factor: 3.116

2.  Integrin inhibition through Lyn-dependent cross talk from CXCR4 chemokine receptors in normal human CD34+ marrow cells.

Authors:  Yuji Nakata; Brian Tomkowicz; Alan M Gewirtz; Andrzej Ptasznik
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

Review 3.  Pleiotropic roles of Notch signaling in normal, malignant, and developmental hematopoiesis in the human.

Authors:  Rahul Kushwah; Borhane Guezguez; Jung Bok Lee; Claudia I Hopkins; Mickie Bhatia
Journal:  EMBO Rep       Date:  2014-09-24       Impact factor: 8.807

Review 4.  Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.

Authors:  Sonali P Barwe; Anthony Quagliano; Anilkumar Gopalakrishnapillai
Journal:  Semin Oncol       Date:  2017-07-11       Impact factor: 4.929

5.  Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia.

Authors:  Xavier Cahu; Julien Calvo; Sandrine Poglio; Nais Prade; Benoit Colsch; Marie-Laure Arcangeli; Thierry Leblanc; Arnaud Petit; Frederic Baleydier; Andre Baruchel; Judith Landman-Parker; Christophe Junot; Jerome Larghero; Paola Ballerini; Eric Delabesse; Benjamin Uzan; Francoise Pflumio
Journal:  Blood Adv       Date:  2017-09-08

6.  The Integrin LFA-1 Controls T Follicular Helper Cell Generation and Maintenance.

Authors:  Alexandre P Meli; Ghislaine Fontés; Danielle T Avery; Scott A Leddon; Mifong Tam; Michael Elliot; Andre Ballesteros-Tato; Jim Miller; Mary M Stevenson; Deborah J Fowell; Stuart G Tangye; Irah L King
Journal:  Immunity       Date:  2016-10-18       Impact factor: 31.745

7.  Epigenetic drug combination overcomes osteoblast-induced chemoprotection in pediatric acute lymphoid leukemia.

Authors:  Anthony Quagliano; Anilkumar Gopalakrishnapillai; Sonali P Barwe
Journal:  Leuk Res       Date:  2017-01-27       Impact factor: 3.156

8.  Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance.

Authors:  Rodrigo Jacamo; Ye Chen; Zhiqiang Wang; Wencai Ma; Min Zhang; Erika L Spaeth; Ying Wang; Venkata L Battula; Po Yee Mak; Katharina Schallmoser; Peter Ruvolo; Wendy D Schober; Elizabeth J Shpall; Martin H Nguyen; Dirk Strunk; Carlos E Bueso-Ramos; Sergej Konoplev; R Eric Davis; Marina Konopleva; Michael Andreeff
Journal:  Blood       Date:  2014-03-05       Impact factor: 22.113

Review 9.  Contribution of bone microenvironment to leukemogenesis and leukemia progression.

Authors:  F Ayala; R Dewar; M Kieran; R Kalluri
Journal:  Leukemia       Date:  2009-09-03       Impact factor: 11.528

10.  Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils.

Authors:  Andrew Filer; Greg Parsonage; Emily Smith; Chloe Osborne; Andrew M C Thomas; S John Curnow; G Ed Rainger; Karim Raza; Gerard B Nash; Janet Lord; Mike Salmon; Christopher D Buckley
Journal:  Arthritis Rheum       Date:  2006-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.